Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Co-amoxiclav 250mg/125mg dispersible tablets sugar free |
| BNF code | 0501013K0AAABAB |
| Virtual Therapeutic Moiety | Co-amoxiclav |
| Date identifier became valid | 23 Sep 2020 |
| Previous product identifier | 323564007 |
| Basis of preferred name | BAN - British Approved Name |
| Date of name applicability | 1 Sep 2007 |
| Previous name | Co-amoxiclav 250mg/125mg dispersible tablets |
| Basis of previous name | BAN - British Approved Name |
| Reason for name change | Other |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✓ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Non-availability | Actual Products not Available |
| Non-availability status date | 1 Jun 2010 |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | tablet |
| Unit dose unit of measure | tablet |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Amoxicillin trihydrate |
| Basis of pharmaceutical strength | Based on Base Substance |
| Basis of strength substance identifier | 372687004 |
| Strength value numerator | 250.000 |
| Strength value numerator unit | mg |
| Virtual Product Ingredient | |
| Ingredient | Potassium clavulanate |
| Basis of pharmaceutical strength | Based on Base Substance |
| Basis of strength substance identifier | 395939008 |
| Strength value numerator | 125.000 |
| Strength value numerator unit | mg |
| Ontology Drug Form & Route | |
| Form & Route | suspension.oral |
| Dose Form | |
| Formulation | Dispersible tablet |
| Drug Route | |
| Route | Oral |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Virtual Medicinal Product Packs | |
| Co-amoxiclav 250mg/125mg dispersible tablets sugar free 21 tablet | |
dm+d data retrieved from TRUD: release NHSBSA_11.0.0_20251103000001, imported on 4th November 2025 at 04:00:10.